share_log

Panbela Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Panbela Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Panbela Therapeutics | S-1/A：证券上市注册声明(修正)
美股SEC公告 ·  08/16 17:28
Moomoo AI 已提取核心信息
Panbela Therapeutics, Inc. has announced a public offering of 1,460,318 shares of common stock, an equal number of Class G and Class H common warrants, and up to 1,460,318 pre-funded warrants to purchase common stock. The offering also includes up to 5,222,223 shares of common stock underlying the warrants. The company has granted the underwriters an option to purchase additional shares and/or warrants to cover over-allotments. The proceeds from the offering are intended for the continued clinical development of Panbela's product candidates, repayment of debt, and general corporate purposes. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Panbela Therapeutics, Inc. has announced a public offering of 1,460,318 shares of common stock, an equal number of Class G and Class H common warrants, and up to 1,460,318 pre-funded warrants to purchase common stock. The offering also includes up to 5,222,223 shares of common stock underlying the warrants. The company has granted the underwriters an option to purchase additional shares and/or warrants to cover over-allotments. The proceeds from the offering are intended for the continued clinical development of Panbela's product candidates, repayment of debt, and general corporate purposes. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Panbela Therapeutics，Inc.宣布进行公开发行1,460,318股普通股，相同数量的G类和H类普通股权证，以及高达1,460,318预融资的购股权证。该发行还包括多达5,222,223股普通股票作为权证的基础。公司已授予承销商购买额外股票和/或权证的选择权以弥补超额分配。发行所得拟用于Panbela的产品候选继续进行临床开发、偿还债务和一般性企业用途。发行受市场情况影响，不能保证是否完成发行以及完成发行的时间，或者发行规模或条款的实际情况。
Panbela Therapeutics，Inc.宣布进行公开发行1,460,318股普通股，相同数量的G类和H类普通股权证，以及高达1,460,318预融资的购股权证。该发行还包括多达5,222,223股普通股票作为权证的基础。公司已授予承销商购买额外股票和/或权证的选择权以弥补超额分配。发行所得拟用于Panbela的产品候选继续进行临床开发、偿还债务和一般性企业用途。发行受市场情况影响，不能保证是否完成发行以及完成发行的时间，或者发行规模或条款的实际情况。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息